929882-85-9

Upstream product

• 929882-84-8 (2S,3R,4R,5R,7R,9S)-10-(benzyloxy)-5,7,9-tris(tert-butyldimethylsilyloxy)-3-(4-methoxybenzyloxy)-2,4-dimethyldecan-1-ol 
• 929882-93-9 (R)-3-((2R,3S,4R,5R,7R,9S)-10-(benzyloxy)-5,7,9-tris(tert-butyldimethylsilyloxy)-3-hydroxy-2,4-dimethyldecanoyl)-4-benzyloxazolidin-2-one 
• 929882-83-7 (R)-3-((2R,3S,4S,5R,7R,9S)-10-(benzyloxy)-7,9-bis(tert-butyldimethylsilyloxy)-3,5-dihydroxy-2,4-dimethyldecanoyl)-4-benzyloxazolidin-2-one 
• 929883-07-8 (2S,4R,6R,7R,8R,9S)-2,4,6-tris(tert-butyldimethylsilyloxy)-8-(4-methoxybenzyloxy)-7,9-dimethyl-10-(triethylsilyloxy)decan-1-ol 

Downstream Products

• 1026559-05-6 C₇₃H₁₂₉NO₉Si₆ 

Relevant academic research and scientific papers

Enantioselective synthesis of oasomycin A, part II: Synthesis of the C29-C46 subunit

(Chemical Equation Presented) Putting the pieces together: The total synthesis of the natural macrolide oasomycin A has been realized. Key fragment couplings include an anti-Felkin selective aldol addition (green), Kociensky-Julia olefinations (red), and